2007Chinese Remedies & ClinicsRequires access

Effects of soybeanisoflavone on serum SOD, MDA, GSH and NO in rats with type two dlabetes

LU Cai-lin

Open publisher page 0 citations

Abstract

Objective To observe the effects of soybeanisoflavone on serum levels of superoxide dismutase (SOD),malonyldialdehede (MDA), reduced glutathione hormone (GSH) and nitric oxide (NO) in rats with type 2 diabetes. Methods SD rats fed on high-fat diet for 4 weeks were given intraperitoneal injection of small-dose STZ to induce type two diabetes. These experimental models were then randomized into the usual diet control group, diabetes control group, 250 mg/kg and 50 mg/kg soybeanisoflavone groups. Levels of blood sugar were detected after 6 weeks and changes in serum levels of SOD, MDA, GSH and NO were detected after 10 weeks in each group. Results Compared with diabetes control group, the level of SOD increased significantly in 250 mg/kg soybeanisoflavone group (P0.05), while the level of MDA and NO decreased markedly(P0.05), and the level of serum GSH was elevated in 50 mg/kg soybeanisoflavone group (P0.05). Conclusion Soybeanisoflavone may improve antioxidation in rats with type two diabetes.

About this research paper

What this paper is about

Objective To observe the effects of soybeanisoflavone on serum levels of superoxide dismutase (SOD),malonyldialdehede (MDA), reduced glutathione hormone (GSH) and nitric oxide (NO) in rats with type 2 diabetes. Methods SD rats fed on high-fat diet for 4 weeks were given intraperitoneal injection of small-dose STZ to induce type two diabetes. These experimental models were then randomized into the usual diet control group, diabetes control group, 250 mg/kg and 50 mg/kg soybeanisoflavone groups. Levels of blood sugar were detected after 6 weeks and changes in serum levels of SOD, MDA, GSH and NO were detected after 10 weeks in each group. Results Compared with diabetes control group, the level of SOD increased significantly in 250 mg/kg soybeanisoflavone group (P0.05), while the level of MDA and NO decreased markedly(P0.05), and the level of serum GSH was elevated in 50 mg/kg soybeanisoflavone group (P0.05). Conclusion Soybeanisoflavone may improve antioxidation in rats with type two diabetes.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effects of soybeanisoflavone on serum levels of superoxide dismutase (SOD),malonyldialdehede (MDA), reduced glutathione hormone (GSH) and nitric oxide (NO) in rats with type 2 diabetes. Methods SD rats fed on high-fat diet for 4 weeks were given intraperitoneal injection of small-dose STZ to induce type two diabetes. These experimental models were then randomized into the usual diet control group, diabetes control group, 250 mg/kg and 50 mg/kg soybeanisoflavone groups. Levels of blood sugar were detected after 6 weeks and changes in serum levels of SOD, MDA, GSH and NO were detected after 10 weeks in each group. Results Compared with diabetes control group, the level of SOD increased significantly in 250 mg/kg soybeanisoflavone group (P0.05), while the level of MDA and NO decreased markedly(P0.05), and the level of serum GSH was elevated in 50 mg/kg soybeanisoflavone group (P0.05). Conclusion Soybeanisoflavone may improve antioxidation in rats with type two diabetes.

Key concepts: Endocrinology, Internal medicine, Type 2 diabetes, Glutathione, Superoxide dismutase, Nitric oxide, Intraperitoneal injection, Diabetes mellitus

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of soybeanisoflavone on serum SOD, MDA, GSH and NO in rats with type two dlabetes — Research Paper | ScholarLens